Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8178978rdf:typepubmed:Citationlld:pubmed
pubmed-article:8178978lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8178978lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8178978lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:8178978lifeskim:mentionsumls-concept:C0031686lld:lifeskim
pubmed-article:8178978lifeskim:mentionsumls-concept:C0332325lld:lifeskim
pubmed-article:8178978lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:8178978pubmed:issue4 Pt 1lld:pubmed
pubmed-article:8178978pubmed:dateCreated1994-6-9lld:pubmed
pubmed-article:8178978pubmed:abstractTextReduced type 1 protein phosphatase (PP-1) activity in human muscle extracts may contribute to the reduced insulin-stimulated glycogen synthase activity associated with insulin resistance for glucose disposal in humans. Because inactive forms of PP-1 can be activated with trypsin plus Mn2+, these reagents were used to compare the PP-1 activities in skeletal muscle extracts before and after separation into cytosolic and glycogen microsomal (GM) fractions. PP-1 activities were reduced in the GM fraction from insulin-resistant subjects (54 +/- 2 vs. 61 +/- 1, P < 0.01) but, in contrast to our previously published results, were elevated in the extract (33 +/- 6 vs. 18 +/- 3, P < 0.05). Recombination of the cytosol and GM fractions (reconstituted extract) demonstrated that the low extract PP-1 activities could only be regenerated when the GM fraction from insulin-sensitive subjects was recombined with cytosol from either group. The results indicate that the elevated PP-1 activity observed in extracts of insulin-resistant compared with insulin-sensitive subjects is caused by an inhibitor of extract PP-1 activity that sediments with the GM pellet and is more active in the insulin-sensitive subjects.lld:pubmed
pubmed-article:8178978pubmed:languageenglld:pubmed
pubmed-article:8178978pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8178978pubmed:citationSubsetIMlld:pubmed
pubmed-article:8178978pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8178978pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8178978pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8178978pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8178978pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8178978pubmed:statusMEDLINElld:pubmed
pubmed-article:8178978pubmed:monthAprlld:pubmed
pubmed-article:8178978pubmed:issn0002-9513lld:pubmed
pubmed-article:8178978pubmed:authorpubmed-author:MoriHHlld:pubmed
pubmed-article:8178978pubmed:authorpubmed-author:MenzM JMJlld:pubmed
pubmed-article:8178978pubmed:authorpubmed-author:StoneKKlld:pubmed
pubmed-article:8178978pubmed:issnTypePrintlld:pubmed
pubmed-article:8178978pubmed:volume266lld:pubmed
pubmed-article:8178978pubmed:ownerNLMlld:pubmed
pubmed-article:8178978pubmed:authorsCompleteYlld:pubmed
pubmed-article:8178978pubmed:paginationE574-82lld:pubmed
pubmed-article:8178978pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:meshHeadingpubmed-meshheading:8178978-...lld:pubmed
pubmed-article:8178978pubmed:year1994lld:pubmed
pubmed-article:8178978pubmed:articleTitleTrypsin-Mn(2+)-resistant form of type 1 protein phosphatase in human muscle.lld:pubmed
pubmed-article:8178978pubmed:affiliationClinical Diabetes and Nutrition Section, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016.lld:pubmed
pubmed-article:8178978pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8178978lld:pubmed